Greta Verheyen
Overview
Explore the profile of Greta Verheyen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
51
Citations
791
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Regin M, Lei Y, Couvreu de Deckersberg E, Janssens C, Huyghebaert A, Guns Y, et al.
Elife
. 2024 Dec;
12.
PMID: 39652462
About 70% of human cleavage stage embryos show chromosomal mosaicism, falling to 20% in blastocysts. Chromosomally mosaic human blastocysts can implant and lead to healthy new-borns with normal karyotypes. Studies...
2.
Adriaenssens T, Van Vaerenbergh I, Van Landuyt L, Verheyen G, De Brucker M, Camus M, et al.
PLoS One
. 2024 Jan;
19(1):e0297040.
PMID: 38295095
Research Question: Can a strategy for scoring oocyte quality, based on cumulus cell (CC) gene expression, prioritize oocytes with the highest implantation potential, while limiting the number of embryos to...
3.
Regin M, Essahib W, Demtschenko A, Dewandre D, David L, Gerri C, et al.
Hum Reprod
. 2023 Jun;
38(8):1484-1498.
PMID: 37295962
Study Question: Which processes and transcription factors specify the first and second lineage segregation events during human preimplantation development? Summary Answer: Differentiation into trophectoderm (TE) cells can be initiated independently...
4.
Belva F, Blockeel C, Keymolen K, Buysse A, Bonduelle M, Verheyen G, et al.
Fertil Steril
. 2023 Feb;
119(6):932-941.
PMID: 36774979
Objective: To assess health outcomes, including growth up to 2 years of age, in children born after embryo vitrification in comparison with children born after fresh embryo transfer. Design: A...
5.
Mateizel I, Santos-Ribeiro S, Segers I, Wouters K, Mackens S, Verheyen G
J Assist Reprod Genet
. 2022 May;
39(6):1235.
PMID: 35543805
No abstract available.
6.
Mateizel I, Santos-Ribeiro S, Segers I, Wouters K, Mackens S, Verheyen G
J Assist Reprod Genet
. 2022 Mar;
39(6):1225-1232.
PMID: 35357606
Purpose: To investigate whether treatment with commercially available ready-to-use A23187 ionophore (GM508-CultActive) improves embryo development outcome in patients with a history of embryo developmental problems. Methods: This is a uni-center...
7.
Van den Haute L, Drakopoulos P, Verheyen G, De Vos M, Tournaye H, Blockeel C
Reprod Biomed Online
. 2021 Sep;
43(4):655-662.
PMID: 34474975
Research Question: Are cumulative live birth rates (CLBR) after follitropin alpha (Ovaleap®) and follitropin beta (Puregon®) similar when used for ovarian stimulation with ICSI (intracytoplasmic sperm injection) in a first-rank...
8.
Van Reckem M, Blockeel C, Bonduelle M, Buysse A, Roelants M, Verheyen G, et al.
Hum Reprod Open
. 2021 Apr;
2021(2):hoab013.
PMID: 33869795
[This corrects the article DOI: 10.1093/hropen/hoab002.].
9.
Drakopoulos P, Bardhi E, Scherer S, Blockeel C, Verheyen G, Anckaert E, et al.
Reprod Sci
. 2021 Apr;
28(10):2822.
PMID: 33826101
No abstract available.
10.
Drakopoulos P, Bardhi E, Scherer S, Blockeel C, Verheyen G, Anckaert E, et al.
Reprod Sci
. 2021 Mar;
28(10):2816-2821.
PMID: 33751499
To investigate whether there is an association between androgens and ovarian reserve, expressed through anti-Mullerian hormone. This is a retrospective cross-sectional analysis of all consecutive women attending a tertiary fertility...